Cargando…

Moderate hypofractionation remains the standard of care for whole-breast radiotherapy in breast cancer: Considerations regarding FAST and FAST-Forward

Moderate hypofractionation is the standard of care for adjuvant whole-breast radiotherapy after breast-conserving surgery for breast cancer. Recently, 10-year results from the FAST and 5‑year results from the FAST-Forward trial evaluating adjuvant whole-breast radiotherapy in 5 fractions over 5 week...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krug, David, Baumann, René, Combs, Stephanie E., Duma, Marciana Nona, Dunst, Jürgen, Feyer, Petra, Fietkau, Rainer, Haase, Wulf, Harms, Wolfgang, Hehr, Thomas, Piroth, Marc D., Sedlmayer, Felix, Souchon, Rainer, Strnad, Vratislav, Budach, Wilfried
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841378/ https://www.ncbi.nlm.nih.gov/pubmed/33507331 http://dx.doi.org/10.1007/s00066-020-01744-3

Ejemplares similares

Post-neoadjuvant treatment with capecitabine and trastuzumab emtansine in breast cancer patients—sequentially, or better simultaneously?
por: Piroth, Marc D., et al.
Publicado: (2020)

Oligometastasis in breast cancer—current status and treatment options from a radiation oncology perspective
por: Piroth, Marc D., et al.
Publicado: (2022)

Heart toxicity from breast cancer radiotherapy: Current findings, assessment, and prevention
por: Piroth, Marc D., et al.
Publicado: (2018)

DEGRO practical guideline for partial-breast irradiation
por: Strnad, V., et al.
Publicado: (2020)

Current controversies in radiotherapy for breast cancer
por: Krug, David, et al.
Publicado: (2017)

DEGRO practical guidelines for radiotherapy of breast cancer V: Therapy for locally advanced and inflammatory breast cancer, as well as local therapy in cases with synchronous distant metastases
por: Budach, Wilfried, et al.
Publicado: (2015)

DEGRO practical guidelines for radiotherapy of breast cancer VI: therapy of locoregional breast cancer recurrences
por: Harms, Wolfgang, et al.
Publicado: (2016)

DEGRO practical guidelines: radiotherapy of breast cancer I: Radiotherapy following breast conserving therapy for invasive breast cancer
por: Sedlmayer, F., et al.
Publicado: (2013)

Erratum to: DEGRO practical guidelines for radiotherapy of breast cancer V: Therapy for locally advanced and inflammatory breast cancer, as well as local therapy in cases with synchronous distant metastases
por: Budach, Wilfried, et al.
Publicado: (2015)

Reply to: The challenge of cardiac dose constraint adaptation to hypofractionated breast radiotherapy in clinical practice
por: Piroth, Marc D., et al.
Publicado: (2021)

Effect of hypofractionation on the incidental axilla dose during tangential field radiotherapy in breast cancer
por: Borm, Kai J., et al.
Publicado: (2020)

Are heart toxicities in breast cancer patients important for radiation oncologists? A practice pattern survey in German speaking countries
por: Duma, Marciana Nona, et al.
Publicado: (2017)

Deep inspiration breath-hold for left-sided breast irradiation: Analysis of dose-mass histograms and the impact of lung expansion
por: Oechsner, Markus, et al.
Publicado: (2019)

A Comprehensive Prospective Comparison of Acute Skin Toxicity after Hypofractionated and Normofractionated Radiation Therapy in Breast Cancer
por: Borm, Kai J., et al.
Publicado: (2021)

Das Lymphödemrisiko von Mammakarzinompatientinnen nach Operation oder Strahlentherapie der Axilla
por: Duma, Marciana-Nona
Publicado: (2021)

Outcomes of immediate oncoplastic surgery and adjuvant radiotherapy in breast cancer patients
por: Borm, Kai Joachim, et al.
Publicado: (2019)

Tangential Field Radiotherapy for Breast Cancer—The Dose to the Heart and Heart Subvolumes: What Structures Must Be Contoured in Future Clinical Trials?
por: Duma, Marciana Nona, et al.
Publicado: (2017)

Comparing Local and Systemic Control between Partial- and Whole-Breast Radiotherapy in Low-Risk Breast Cancer—A Meta-Analysis of Randomized Trials
por: Haussmann, Jan, et al.
Publicado: (2021)

Breast clinical target volume: HU-based glandular CTVs and ESTRO CTVs in modern and historical radiotherapy treatment planning
por: Duma, Marciana Nona, et al.
Publicado: (2021)

External-Beam-Accelerated Partial-Breast Irradiation Reduces Organ-at-Risk Doses Compared to Whole-Breast Irradiation after Breast-Conserving Surgery
por: Ott, Oliver J., et al.
Publicado: (2023)

MRI based neuroanatomical segmentation in breast cancer patients: leptomeningeal carcinomatosis vs. oligometastatic brain disease vs. multimetastastic brain disease
por: Mayinger, Michael, et al.
Publicado: (2019)

Kardioonkologie: Herzdosis während einer Radiotherapie im Thoraxbereich
por: Duma, Marciana-Nona, et al.
Publicado: (2021)

Ösophaguskarzinom: Prognoseverbesserung durch neoadjuvante Radiochemotherapie
por: Knippen, Stefan, et al.
Publicado: (2021)

External Beam Accelerated Partial Breast Irradiation in Early Breast Cancer and the Risk for Radiogenic Pneumonitis
por: Ott, Oliver J., et al.
Publicado: (2022)

Incidental dose distribution to locoregional lymph nodes of breast cancer patients undergoing adjuvant radiotherapy with tomotherapy - is it time to adjust current contouring guidelines to the radiation technique?
por: Mayinger, Michael, et al.
Publicado: (2019)

Accelerated Partial Breast Irradiation: Macrophage Polarisation Shift Classification Identifies High-Risk Tumours in Early Hormone Receptor-Positive Breast Cancer
por: Schnellhardt, Sören, et al.
Publicado: (2020)

Neuroanatomical changes seen in MRI in patients with cerebral metastasized breast cancer after radiotherapy
por: Reibelt, Antonia, et al.
Publicado: (2021)

The in vitro immunogenic potential of caspase-3 proficient breast cancer cells with basal low immunogenicity is increased by hypofractionated irradiation
por: Kötter, Bernhard, et al.
Publicado: (2015)

Primary radio(chemo)therapy for esophageal cancer in elderly patients: are efficiency and toxicity comparable with younger patients?
por: Münch, Stefan, et al.
Publicado: (2017)

Tumour-Infiltrating Inflammatory Cells in Early Breast Cancer: An Underrated Prognostic and Predictive Factor?
por: Schnellhardt, Sören, et al.
Publicado: (2020)

Dosimetric impact of different CT datasets for stereotactic treatment planning using 3D conformal radiotherapy or volumetric modulated arc therapy
por: Oechsner, Markus, et al.
Publicado: (2015)

Registration uncertainties between 3D cone beam computed tomography and different reference CT datasets in lung stereotactic body radiation therapy
por: Oechsner, Markus, et al.
Publicado: (2016)

Moving targets in 4D-CTs versus MIP and AIP: comparison of patients data to phantom data
por: Borm, Kai Joachim, et al.
Publicado: (2018)

Hypofractionated Whole Breast Irradiation and Boost-IOERT in Early Stage Breast Cancer (HIOB): First Clinical Results of a Prospective Multicenter Trial (NCT01343459)
por: Fastner, Gerd, et al.
Publicado: (2022)

Hypofractionation with simultaneous integrated boost after breast-conserving surgery: Long term results of two phase-II trials
por: Pfaffendorf, Charlotte, et al.
Publicado: (2022)

Benchmarking halcyon ring delivery system for hypofractionated breast radiotherapy: Validation and clinical implementation of the fast‐forward trial
por: Pokhrel, Damodar, et al.
Publicado: (2023)

Low doses to the heart in daily practice for treating left-sided breast cancer using accelerated partial-breast irradiation by multicatheter brachytherapy and deep-inspiration breath-hold using a SIB
por: Knippen, Stefan, et al.
Publicado: (2023)

Evaluation of the tumor movement and the reproducibility of two different immobilization setups for image-guided stereotactic body radiotherapy of liver tumors
por: Dreher, Constantin, et al.
Publicado: (2018)

Impact of (18)F-FDG-PET/CT on the identification of regional lymph node metastases and delineation of the primary tumor in esophageal squamous cell carcinoma patients
por: Münch, Stefan, et al.
Publicado: (2020)

Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: results of a prospective trial
por: Krug, David, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k3eqgnv7gm9enghcnvsgi3qd3g